Ir Nrxpharma
Published October 15, 2026
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative ...
Read the full story at Ir Nrxpharma
Ketamine product. The letter requests that the Company submits sample labeling with the proposed proprietary product name currently under review.
Surfaced by this Google Alert
- Ketamine
